US OptionsDetailed Quotes

ATRA240920C7500

Watchlist

0.19
0.000.00%

15min DelayClose Feb 9 11:07 ET

0.00High0.00Low

Atara Biotherapeutics Stock Discussion

Trytosaveabit

Jul 17 08:09

Update! Make a note!

$Atara Biotherapeutics(ATRA.US)$ Reuters· PDUFA for BLA is January 20th
Atara Biotherapeutics- Bla Acceptance Triggers $20 Mln Milestone Payment With Additional $60 Mln Milestone if Approved by FDA

Trytosaveabit

Jun 17 07:08

Update

$Atara Biotherapeutics(ATRA.US)$ Atara Biotherapeutics To Conduct 1-for-25 Reverse Stock Split, Effective Jun. 20

Trytosaveabit

May 29 15:12

Update

$Atara Biotherapeutics(ATRA.US)$ Reuters· 7 mins ago
Atara Biotherapeutics - Preclinical Results Support Advancing ATA3219 Towards Clinical Evaluation in Patients With B-Cell Driven Autoimmune Diseases

Jaguar8

May 29 15:02

NEWS

$Atara Biotherapeutics(ATRA.US)$
Atara Biotherapeutics Presents Preclinical Data on ATA3219, an Allogeneic CD19-Targeted CAR T Therapy for the Treatment of B-Cell Driven Autoimmune Diseases, at the ISCT 2024 Annual Meeting
Atara Biotherapeutics has announced promising preclinical data for ATA3219, an allogeneic CD19-targeted CAR T therapy aimed at treating B-cell driven autoimmune diseases such as systemic lupus erythematosus (SLE) and multiple sclerosis (MS). The data, to be presented at th...

Jaguar8

May 20 08:36

$Atara Biotherapeutics(ATRA.US)$
NEWS
Atara Biotherapeutics Submits Tabelecleucel (Tab-cel®) Biologics License Application for Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S. FDA
05/20/2024 - 06:25 AM First Allogeneic T-Cell Therapy BLA Submission to U.S. Food and Drug Administration If Approved, Tab-cel Would be First Approved Therapy in U.S. for EBV+ PTLD Acceptance of BLA Will Trigger $20 Million Milestone Payment from Pierre Fabre Laboratories, ...

joeyboulevard

May 7 11:50

$Atara Biotherapeutics (ATRA.US)$ looks like in buy range

Sean Parker

Apr 29 09:46

looks like a good day

$Atara Biotherapeutics(ATRA.US)$

Trytosaveabit

Apr 4 17:58

Im just adding a heads up to my previous post about upcoming BLA submission!

$Atara Biotherapeutics(ATRA.US)$ PAY VERY CLOSE ATTENTION TO THE LAST 3 BULLET POINTS! This could be a catalyst for a large price increase? Even if its only a temporary increase? I want you to have ample opportunity to catch ahead of time if YOU CHOOSE? Not me choosing for YOU! NFA! Just a heads up for the possibility! Tab-cel U.S. BLA on Track for Submission in Q2 2024 Following Positive Pre-BLA Me...

Trytosaveabit

Mar 29 15:12

Pay attention to the dates! Make a note !

$Atara Biotherapeutics(ATRA.US)$ Tab-cel U.S. BLA on Track for Submission in Q2 2024 Following Positive Pre-BLA Meeting
Allogeneic CAR T Pipeline Expands Into Autoimmune Disease With Plans To Initiate a ATA3219 Lupus Nephritis Study in H2 2024, and Initial Clinical Data Expected H1 2025
ATA3219 NHL Study Enrolling With Initial Clinical Data Expected in Q4 2024
Cash Runway Into 2027 Enables Key Pipeline Readouts

Trytosaveabit

Mar 18 15:27

New 13G! Did he get tired of naked SS? Hehehe

$Atara Biotherapeutics(ATRA.US)$ Atara Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Citadel Advisors LLC(6.4%),Citadel Advisors Holdings LP(6.4%), etc.
SEC announcement· 4 mins ago

No comment yet